Purpose: The pharmacology, pharmaceutics, clinical efficacy, adverse effects, cost, and dosage and administration of long-acting risperidone injection are reviewed. Summary: Risperidone is the ...

Risperidone is also a potent antagonist at 5-hydroxytryptamine type 2 (5-HT 2) receptors. This may result in a reduced propensity to cause EPSs. [7,27] Risperidone has a high affinity for both 5 ...

Risperidone 0.5mg, 1mg, 2mg, 3mg, 4mg; contains phenylalanine. Initially 2–3mg once daily; may adjust at intervals of at least 24hrs by 1mg/day. Usual range: 1–6mg/day; max 6mg/day.

Find all the commercial and brand names of generic drug called Risperidone. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

Lyndra Therapeutics®, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, today announced the ...

Risperidone 12.5mg, 25mg, 37.5mg, 50mg; per vial; pwd for long-acting IM inj after reconstitution. Risperidone-naive: rule out risperidone hypersensitivity before using injection. Give by deep ...

Teva's long haul to a turnaround of its business has been dealt a blow by the FDA, which has just declined to approve the company's long-acting formulation of schizophrenia drug risperidone. The ...

Given the favorable results, Lyndra elected to stop the study early. The biotech’s long-acting risperidone candidate is slated to enter a phase 3 safety trial in the first half of 2025.

Lyndra’s long-acting oral therapies, including lead investigational product oral weekly risperidone (LYN-005), are designed to deliver medication for a week or longer with a single oral dose.

Lyndra’s long-acting oral therapies, including lead investigational product oral weekly risperidone (LYN-005), are designed to deliver medication for a week or longer with a single oral dose.